Wegovy

2022 - 3 - 21

wegovy ireland

New obesity drug approved for use in Ireland (RTE.ie)

"The unprecedented level of weight loss this medication achieves marks a new era in the treatment of this disease. "Wegovy may be a foundation drug that can ...

Then we know the medication is working." He said the drug may not work for people who have what is termed a "cultural desire for thinness" because it works really only for people with the disease of obesity. Clinical trials found that Wegovy was found to affect weight loss of 17% in patients who took it every week for a year.

New weight wonderdrug introduced across Ireland this week (Donegal Daily)

The drug, Wegovy, has been found to reduce bodyweight by between three and four stone. Now the European Medicines Agency has approved the drug for use in Ireland. People fighting weight gain can now avail of the drug by taking weekly injections.

Wegovy may be a foundation drug that can revolutionise the management of obesity. “The unprecedented level of weight loss this medication achieves marks a new era in the treatment of this disease. People fighting weight gain can now avail of the drug by taking weekly injections.

New weight-loss drug approved for use in Ireland (BreakingNews.ie)

The drug, known as Wegovy, is delivered by weekly injection and is used together with diet and physical activity to help people to lose weight and keep ...

According to Dr O'Shea, although the drug has been used to treat diabetes for over a decade and is safe, it will not be the right treatment for everyone. "We need it to be covered by the HSE for people who will benefit from it because this medication will strop you from developing some of the complications of obesity like type 2 diabetes and high blood pressure. A new drug which can dramatically reduce body weight has been approved by the European Medicines Agency (EMA) for use in Ireland and across Europe.

Wegovy: All you need to know about new 'appetite jab' approved for ... (Dublin Live)

The EMA has approved the use of a new drug called Wegovy, which has been described as the "most effective obesity treatment". This jab will be a treatment ...

This should result in the person eating less which will lead to weight loss. Those who suffer from clinical obesity will benefit the most from Wegovy. Those who suffer from health complications because of their body weight and struggle with daily tasks because of their weight. He was speaking to Claire Byrne on RTE Radio this morning to share more information about this new treatment, how it works, who will benefit the most from it and how is it administered.

'Game-changing' weight loss medication approved for use in Ireland (Buzz.ie)

The weight loss medication was found to bring about weight loss of 17 per cent – an average of three to four stone – in patients who took the drug every ...

In addition, 67 per cent of people in the Wegovy group were able to lose at least 5 per cent of their weight compared with 30 per cent of people in the placebo group. Around 85 pre cent of people in the Wegovy group lost at least 5 per cent of their weight compared with 48 per cent of people in the placebo group. In the first of these studies, involving 1,961 people, people treated with Wegovy were able to lose on average 15 per cent of their body weight after 68 weeks compared with a 2 per cent loss of weight in people who had placebo. In the second study, involving 611 people, those treated with Wegovy lost on average 16 per cent of their body weight after 68 weeks compared with a 6 per cent loss of weight in people who had placebo. After 68 weeks, those treated with Wegovy were able on average to lose 10 per cent of their weight compared with a 3 per cent loss in people who had placebo. In its clinical trial Wegovy was found to affect weight loss of 17 per cent (3-4 stone), in patients who took the drug every week for a year.

Weight loss drug has potential to 'revolutionise weight management' (Newstalk)

Studies show a weekly prescription injection of Wegovy can reduce body fat weight by up to one-fifth over the course of a year. The drug has been approved by ...

"Telling somebody who's living with excess weight to eat less and move more, long-term... "This is one of the big issues: the HSE and the Department of Health need to fund and reimburse these medications so they can be available. "We don't know what the cost point is going to be, that's one of the biggest challenges. "Treating the biological drive, treating the parts of the brain we can't control to turn down the volume on our drive towards food". "So our hunger levels, our fullness levels, the reward and chemical reaction to food is all going on in the subconscious brain and we can't change that. "The genetics - we know that somewhere between 40% and 70% of our risk of struggling with weight is genetically conferred.